Central nervous system activities of two diterpenes isolated from Aloysia virgata

Phytomedicine

Volumn 18, Issue 5, 2011, Pages 393-401

  Wasowski, Cristina ^a   Marder, Mariel ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Aloysia virgata; Anxiety; Benzodiazepine binding site ligand; GABA A receptor; Phyllocladane diterpenoids

Indexed keywords

16,17 DIHYDROXYPHYLLOCLADAN 3 ONE; 16,17,18 TRIHYDROXYPHYLLOCLADAN 3 ONE; 4 AMINOBUTYRIC ACID RECEPTOR; DIAZEPAM; DITERPENE; TERPENOID; UNCLASSIFIED DRUG;

ALOYSIA VIRGATA; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; EXPERIMENTAL TEST; HOLEBOARD TEST; LIGHT DARK TRANSITION TEST; LOCOMOTION; MALE; MAZE TEST; MEDICINAL PLANT; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; BEHAVIOR, ANIMAL; BINDING SITES; BINDING, COMPETITIVE; BRAIN; DARKNESS; DITERPENES; FLUNITRAZEPAM; LIGHT; MALE; MAZE LEARNING; MICE; MICE, INBRED ICR; MODELS, ANIMAL; MOTOR ACTIVITY; PLANT EXTRACTS; RECEPTORS, GABA-A; VERBENACEAE;

ALOYSIA; MUS; PAVON;

EID: 79952738251     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2010.08.017     Document Type: Article

References (21)

1. Bassols, G., Gurni, A., 1996. Especies del género Lippia utilizadas en medicina popular Latinoamericana. Dominguezia 13, 7-24.
2. Bourin, M., Hascoet, M., Bouzekri, M., Colombel, M.C., Bradwejn, J., 1992. Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models. J. Psychiatr. Neurosci. 17, 72-77.
3. Cryan, J.F., Holmes, A., 2005. The ascent of mouse: advances in modelling human depression and anxiety. Nat. Rev. Drug Discov. 4, 775-790.
4. de Oliveira, C.M.A., da Silva, C.C., Ferreira, H.D., de Fatima Lemes, G., Schmitt, E., 2005. Kauranes, phenylethanoids and flavone from Aloysia virgata. Biochem. Syst. Ecol. 33, 1191-1193.
5. Ernst, E., 2006. Herbal remedies for anxiety - a systematic review of controlled clinical trials. Phytomedicine 13, 205-208. (Pubitemid 43120323)
6. Fernández, S.P., Wasowski, C., Paladini, A.C., Marder, M., 2006. Central nervous system depressant action of flavonoid glycosides. Eur. J. Pharmacol. 539, 168-176.
7. Gardner, C.R., Tully, W.R., Hedgecock, C.J.R., 1993. The rapidly expanding range of neuronal benzodiazepine receptor ligands. Prog. Neurobiol. 40, 1-61.
8. Haider, F., Bagchi, G.D., Singh, A.K., 2009. Effect of calliterpenone on growth, herb yield and oil quality of Mentha arvensis. Int. J. Integr. Biol. 7, 53-57.
9. Hellión-Ibarrola, M.C., Ibarrola, D.A., Montalbetti, Y., Kennedy, M.L., Heinichen, O., Campuzano, M., Tortoriello, J., Fernández, S., Wasowski, C., Marder, M., De Lima, T.C.M., Mora, S., 2006. The anxiolytic-like effects of Aloysia polystachya (Griseb.) Moldenke (Verbenaceae) in mice. J. Ethnopharmacol. 105, 400-408.
10. Jaensch, M., Jakupovic, J., Sanchez, H., Dominguez, X.A., 1990. Diterpenes from Hoffmannia strigillosa. Phytochemistry 29, 3587-3590.
11. Johnston, G.A.R., Hanrahan, J.R., Chebib, M., Duke, R.K., Mewett, K.N., 2006. Modulation of ionotropic GABA receptors by natural products of plant origin. Adv. Pharmacol. 54, 285-316.
12. Lader, M.H., 1999. Limitations on the use of benzodiazepines in anxiety and insomnia: are they justify? Eur. Neuropsychopharmacol. 9, s399-s405. (Pubitemid 30089072)
13. Liberzon, I., Phan, K.L., Khan, S., Abelson, J.L., 2003. Role of the GABAA receptor in anxiety: evidence from animal models, molecular and clinical psychopharmacology, and brain imaging studies. Curr. Neuropharm. 1, 267-283.
14. Lister, R.G., 1987. The use of a plus maze to measure anxiety in the mouse. Psychopharmacology (Berl.) 92, 180-185. (Pubitemid 17072893)
15. Liu, G., Müller, Rüedi, P., 2003. Chemical transformations of phyllocladane (=13β-Kaurane) diterpenoids. Helv. Chim. Acta 86, 420-438.
16. Marder, M., Paladini, A.C., 2002. GABAA-receptor ligands of flavonoid structure. Curr. Top. Med. Chem. 2, 853-867.
17. Marder, M., Viola, H., Wasowski, C., Fernández, S., Medina, J.H., Paladini, A.C., 2003. 6-Methylapigenin and hesperidin: new valeriana flavonoids with activity on the CNS. Pharmacol. Biochem. Behav. 75, 737-745.
18. Pillay, N.S., Stein, D.J., 2007. Emerging anxiolytics. Expert Opin. Emerg. Drugs 12, 541-554.
19. Takeda, H., Tsuji, M., Matsumiya, T., 1998. Changes in head-dipping behavior in the hole board test reflect the anxiogenic and/or anxiolytic state in mice. Eur. J. Pharmacol. 350, 9-21.
20. Wang, Q., Han, Y., Xue, H., 1999. Ligands of GABAA receptor benzodiazepine binding site. CNS Drug Rev. 5, 125-144. (Pubitemid 29451456)
21. Zhang, Z.J., 2004. Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders. Life Sci. 75, 1659-1699.